Skip Navigation



Hum. Reprod. Advance Access published online on December 16, 2008

Human Reproduction, doi:10.1093/humrep/den415
This Article
Right arrow Full Text
Right arrow Full Text (PDF )
Right arrow Supplementary Data
Right arrow All Versions of this Article:
24/3/590    most recent
den415v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Jain, R. K.
Right arrow Articles by Gupta, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jain, R. K.
Right arrow Articles by Gupta, G.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2008. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

In vitro testing of rationally designed spermicides for selectively targeting human sperm in vagina to ensure safe contraception{dagger}

Rajeev K. Jain1, Ashish Jain1, Jagdamba P. Maikhuri1, Vishnu L. Sharma2, Anil K. Dwivedi3, S.T.V.S. Kiran Kumar2, Kalyan Mitra4, Virendra K. Bajpai4 and Gopal Gupta1,5

1 Division of Endocrinology, Central Drug Research Institute, Lucknow 226 001, India 2 Division of Medicinal Chemistry, Central Drug Research Institute, Lucknow 226 001, India 3 Division of Pharmaceutics, Central Drug Research Institute, Lucknow 226 001, India 4 Electron Microscopy Unit, Central Drug Research Institute, Lucknow 226 001, India

5 Correspondence address. Tel: +91-522-2612411 ext. 4396; Fax: +91-522-2624305; E-mail: gupta.gopal{at}rediffmail.com, ji_gupta{at}yahoo.co.in, www.cdriindia.org

BACKGROUND: Rational synthesis of novel structures resulted in two unique molecules (DSE-36 and DSE-37, disulphide esters of carbothioic acid) that killed sperm 25 times more strongly and with a precisely targeted action than nonoxynol-9 (N-9). We examine the effects of DSE-36 and DSE-37 on human spermatozoa versus HeLa cells to establish specificity and safety compared with N-9.

METHODS AND RESULTS: At spermicidal EC100 (20 µg/ml) DSE-36 and DSE-37 killed 100% sperm in <30 s (Sander–Cramer assay) and at EC50 induced apoptosis in sperm (Annexin-V-fluorescein isothiocyanate and JC-1 labelling and Flow Cytometry) in 3 h. However, at EC100 these molecules had no effect on HeLa cells by 24 h or on cell viability [3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide (MTT) assay], surface ultrastructure (scanning electron microscopy), Annexin-V and JC-1 labelling pattern and reactive oxygen species (ROS) generation. N-9, with a spermicidal EC100 of 500 µg/ml, decreased HeLa cell viability at 20 µg/ml in 24 h (P < 0.001), accompanied by acute damage to cell surface ultrastructural topography, induction of apoptosis and ROS generation. Unlike DSE-36 and DSE-37, N-9 also significantly induced mRNA levels (RT–PCR) of pro-inflammatory biomarkers (interleukin (IL)-1{alpha}, IL-6, IL-8, RANTES) in HeLa cells and increased IL-6 and IL-8 secretion (P < 0.001, enzyme-linked immunosorbent assay). Furthermore, DSE-36 and DSE-37 did not inhibit Lactobacillus growth at EC100 and exhibited mild microbicidal activity against Trichomonas vaginalis, while N-9 inhibited Lactobacillus and Trichomonas growth but had a lower prophylactic index.

CONCLUSIONS: The ability of these novel spermicides to kill sperm almost instantaneously at innocuously low concentration indicates their worth as improved active ingredients for vaginal contraceptive preparations compared with N-9.

Key words: DSE-36/spermicides/HeLa/contraception/nonoxynol-9


{dagger} CDRI communication No. 7351.

Submitted on April 2, 2008; resubmitted on August 5, 2008; accepted on September 16, 2008.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.